Literature DB >> 11390353

Malignant glioma: genetics and biology of a grave matter.

E A Maher1, F B Furnari, R M Bachoo, D H Rowitch, D N Louis, W K Cavenee, R A DePinho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11390353     DOI： 10.1101/gad.891601

Source DB:  PubMed          Journal:  Genes Dev        ISSN： 0890-9369            Impact factor:   11.361


× No keyword cloud information.
  430 in total

Review 1.  Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets.

Authors:  A Shir; A Levitzki
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

2.  An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas.

Authors:  Xueyan Zhao; Travis Laver; Suk W Hong; George B Twitty; Annelies Devos; Marijke Devos; Etty N Benveniste; Susan E Nozell
Journal:  J Neurooncol       Date:  2011-01-30       Impact factor: 4.130

3.  EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway.

Authors:  R Bonavia; M M Inda; S Vandenberg; S-Y Cheng; M Nagane; P Hadwiger; P Tan; D W Y Sah; W K Cavenee; F B Furnari
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

Review 4.  Emerging roles of PDGF-D signaling pathway in tumor development and progression.

Authors:  Zhiwei Wang; Aamir Ahmad; Yiwei Li; Dejuan Kong; Asfar S Azmi; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-04-28

5.  E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling.

Authors:  Yanmin Zhang; Zhaoxiao Du; Zirong Zhuang; Yanjun Wang; Fen Wang; Shuai Liu; Han Wang; Hairong Feng; Haoyuan Li; Liyan Wang; Xianghong Zhang; Aijun Hao
Journal:  J Neurooncol       Date:  2015-09-19       Impact factor: 4.130

6.  Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.

Authors:  Ping Guo; Yorihisa Imanishi; Frank C Cackowski; Michael J Jarzynka; Huo-Quan Tao; Ryo Nishikawa; Takanori Hirose; Bo Hu; Shi-Yuan Cheng
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 7.  Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

Authors:  Trent R Hummel; Lionel M Chow; Maryam Fouladi; David Franz
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

8.  Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea.

Authors:  Taichang Jang; Todd Savarese; Hoi Pang Low; Sunchin Kim; Hannes Vogel; David Lapointe; Timothy Duong; N Scott Litofsky; James M Weimann; Alonzo H Ross; Lawrence Recht
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

9.  Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma.

Authors:  Chenzhuo Feng; Ying Zhang; Jinbo Yin; Jun Li; Roger Abounader; Zhiyi Zuo
Journal:  Neuro Oncol       Date:  2014-02-12       Impact factor: 12.300

10.  Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.

Authors:  Fernando Francisco Borges Resende; Simoneide Souza Titze-de-Almeida; Ricardo Titze-de-Almeida
Journal:  Oncol Lett       Date:  2018-02-01       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.